Species: Treponema sp. HMT-231 (HMT-0231) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0231: [Body Sites Data]
[Taxon Description]
| Life Page: Treponema sp. HMT-231
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.35 | 0.12 | 0 | 0.02 | 0.01 | 0.03 | 0.04 | 0.23 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.92 | 0.33 | 0 | 0.03 | 0.01 | 0.06 | 0.04 | 0.28 | 0 | 0 |
| Stdev | 0.80 | 0.38 | 0 | 0.07 | 0.04 | 0.08 | 0.29 | 0.81 | 0.01 | 0 |
| Prev(%) | 48.05 | 24.68 | 1.30 | 12.99 | 10.39 | 23.38 | 15.58 | 32.47 | 6.49 | 0 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to T. vincentii and T. sp. HMT 231 were assigned half to each taxon.
Reads equally close to T. vincentii and T. sp. HMT 231 were assigned half to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.21 | 0.06 | 0 | 0.01 | 0.01 | 0.03 | 0.03 | 0.07 | 0.01 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.57 | 0.20 | 0 | 0.03 | 0.02 | 0.08 | 0.05 | 0.15 | 0.03 | 0 |
| Stdev | 0.44 | 0.17 | 0.01 | 0.06 | 0.02 | 0.04 | 0.15 | 0.23 | 0.03 | 0 |
| Prev(%) | 52.70 | 39.87 | 6.08 | 25.68 | 22.30 | 48.65 | 37.16 | 46.62 | 27.70 | 0 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
Notes:
Because HMT-029 is not present individually, all equidistant reads were assigned to HMT-231 at these sites (PTO,SUPP).
Reads equidistant to HMT-231 and HMT-667 were assigned to each taxon in proportion to the abundance of HMT-231 and HMT-667 individually at these sites (THR,TDO).
Because HMT-029 is not present individually, all equidistant reads were assigned to HMT-231 at these sites (PTO,SUPP).
Reads equidistant to HMT-231 and HMT-667 were assigned to each taxon in proportion to the abundance of HMT-231 and HMT-667 individually at these sites (THR,TDO).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.26 | 0.08 | 0 | 0 | 0 | 0 | 0.05 | 0.14 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.81 | 0.26 | 0 | 0 | 0 | 0 | 0.09 | 0.38 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.51 | 0.21 | 0 | 0 | 0 | 0 | 0.21 | 0.34 | 0.01 | 0 | 0 | 0 | 0 | 0.11 | 0 | 0 | 0 | 0 |
| Prev(%) | 57.62 | 37.75 | 0 | 0 | 0 | 0 | 30.36 | 62.00 | 19.36 | 0 | 0 | 0 | 0 | 1.38 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
Neither HMT-029 nor HMT-231 were present singularly so these reads were split evenly at these sites (SAL,SUPP).
Neither HMT-029 nor HMT-231 were present singularly so these reads were split evenly at these sites (SAL,SUPP).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0.07 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0.22 | 0 | 0 | 0 | 0.16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0.22 | 0 | 0 | 0 | 0.14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 41.22 | 0 | 0 | 0 | 58.33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.08 | 0.01 | 0 | 0 | 0 | 0 | 0.01 | 0.03 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.40 | 0.05 | 0 | 0.01 | 0 | 0 | 0.01 | 0.10 | 0 | 0 |
| Stdev | 0.18 | 0.03 | 0 | 0.01 | 0 | 0 | 0.01 | 0.09 | 0 | 0 |
| Prev(%) | 48.65 | 50.00 | 6.98 | 34.29 | 10.71 | 26.00 | 36.36 | 51.61 | 10.00 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes

